The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7007
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures ; volume:20 ; number:1 ; day:22 ; month:10 ; year:2022 ; pages:1-27 ; date:12.2022
BMC biology ; 20, Heft 1 (22.10.2022), 1-27, 12.2022
- Urheber
-
Bouzón-Arnáiz, Inés
Avalos-Padilla, Yunuen
Biosca, Arnau
Caño-Prades, Omar
Román-Álamo, Lucía
Valle, Javier
Andreu, David
Moita, Diana
Prudêncio, Miguel
Arce, Elsa M.
Muñoz-Torrero, Diego
Fernàndez-Busquets, Xavier
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12915-022-01374-4
- URN
-
urn:nbn:de:101:1-2022112421340737094966
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bouzón-Arnáiz, Inés
- Avalos-Padilla, Yunuen
- Biosca, Arnau
- Caño-Prades, Omar
- Román-Álamo, Lucía
- Valle, Javier
- Andreu, David
- Moita, Diana
- Prudêncio, Miguel
- Arce, Elsa M.
- Muñoz-Torrero, Diego
- Fernàndez-Busquets, Xavier
- SpringerLink (Online service)
Ähnliche Objekte (12)
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy
Mechanisms of microbial co-aggregation in mixed anaerobic cultures
Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance
Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy
Mechanisms of microbial co-aggregation in mixed anaerobic cultures
Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance
Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy
Mechanisms of microbial co-aggregation in mixed anaerobic cultures
Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance
Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4